THIADIAZOLINE DERIVATIVE

see formula (I) (wherein R1 and R4 are the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkynyl, substituted or unsubstituted lower alkenyl, or the like; R5 represents a substituted or unsubstituted heterocyclic g...

Full description

Saved in:
Bibliographic Details
Main Authors KATO, KAZUHIKO, MURAKATA, CHIKARA, YAMASHITA, YOSHINORI, INO, YOJI, NAKAI, RYUICHIRO, TAKAHASHI, TAKESHI, NAKANO, TOMOHISA, OHTA, YOSHIHISA
Format Patent
LanguageEnglish
French
Published 21.06.2011
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract see formula (I) (wherein R1 and R4 are the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkynyl, substituted or unsubstituted lower alkenyl, or the like; R5 represents a substituted or unsubstituted heterocyclic group, substituted or unsubstituted aryl, or the like; R2 represents -C(=W)R6 or the like; R3 represents a hydrogen atom, -C(=WA)R 6A, or the like) Antitumor agents which comprises a thiadiazoline derivative represented by the aforementioned general formula (I) or a pharmacologically acceptable salt thereof as an active ingredient are provided.
AbstractList see formula (I) (wherein R1 and R4 are the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkynyl, substituted or unsubstituted lower alkenyl, or the like; R5 represents a substituted or unsubstituted heterocyclic group, substituted or unsubstituted aryl, or the like; R2 represents -C(=W)R6 or the like; R3 represents a hydrogen atom, -C(=WA)R 6A, or the like) Antitumor agents which comprises a thiadiazoline derivative represented by the aforementioned general formula (I) or a pharmacologically acceptable salt thereof as an active ingredient are provided.
Author MURAKATA, CHIKARA
KATO, KAZUHIKO
TAKAHASHI, TAKESHI
NAKAI, RYUICHIRO
NAKANO, TOMOHISA
YAMASHITA, YOSHINORI
INO, YOJI
OHTA, YOSHIHISA
Author_xml – fullname: KATO, KAZUHIKO
– fullname: MURAKATA, CHIKARA
– fullname: YAMASHITA, YOSHINORI
– fullname: INO, YOJI
– fullname: NAKAI, RYUICHIRO
– fullname: TAKAHASHI, TAKESHI
– fullname: NAKANO, TOMOHISA
– fullname: OHTA, YOSHIHISA
BookMark eNrjYmDJy89L5WSQCPHwdHTxdIzy9_H0c1VwcQ3yDHMM8Qxz5WFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8c6ORiZmlhYGhs7GhFUAAE3tILc
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate DERIVE DE THIADIAZOLINES
ExternalDocumentID CA2469801C
GroupedDBID EVB
ID FETCH-epo_espacenet_CA2469801C3
IEDL.DBID EVB
IngestDate Fri Jul 19 13:57:50 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CA2469801C3
Notes Application Number: CA20022469801
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110621&DB=EPODOC&CC=CA&NR=2469801C
ParticipantIDs epo_espacenet_CA2469801C
PublicationCentury 2000
PublicationDate 20110621
PublicationDateYYYYMMDD 2011-06-21
PublicationDate_xml – month: 06
  year: 2011
  text: 20110621
  day: 21
PublicationDecade 2010
PublicationYear 2011
RelatedCompanies KYOWA HAKKO KOGYO CO., LTD
FUJI PHOTO FILM CO., LTD
RelatedCompanies_xml – name: KYOWA HAKKO KOGYO CO., LTD
– name: FUJI PHOTO FILM CO., LTD
Score 2.8147147
Snippet see formula (I) (wherein R1 and R4 are the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title THIADIAZOLINE DERIVATIVE
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110621&DB=EPODOC&locale=&CC=CA&NR=2469801C
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSUkDtUISjXUTk8xSdE0sk8x1E82BGc_MPDktzcjAGBjroPEOXz8zj1ATrwjTCCaGDNheGPA5oeXgwxGBOSoZmN9LwOV1AWIQywW8trJYPykTKJRv7xZi66KWAhvuMzAzMlRzcbJ1DfB38XdWc3a2dXZU8wuyNQLdlGhg6MzMwApsRJuD8oJrmBNoT0oBcoXiJsjAFgA0K69EiIEpNU-YgdMZdu-aMAOHL3S6G8iE5rxiEQaJEA9PRxdPxyh_H08_VwUXYP8rzDHEM8xVlEHezTXE2UMXaEU83Dfxzo4wtxiLMbAA-_ipEgwKSWmGZklmyQapFskmwA5BmqWpgUGykXmqRSKweWKcaC7JIIHLFCncUtIMXJAhUDNdI0MZBpaSotJUWWAdWpIkB_Y-AH57cmU
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV07T8MwED6VgigbFFB4tgPKFuE8ardDhFInUQJNUqEQVSxRnipLqWgQf59LaIClm2VL57Otz_ew7w7gLi9rLSRRpSSluaRNUiYlDIFHWVaWClHx1Gt_h-dT50V7XIwWHVi2sTBNntCvJjkiIipDvFfNfb3-c2KZzd_KzX36hl3vD3aom2LeuvsIVWTRnOrWPDADLnKuc0P0n3WlrpRIZL4H-6hgsxoLVjStY1LW_wWKfQwHc6S1qk6gU6z60ONt3bU-HHrb525sbpG3OQUhdFzDdI3XYOb61tBE-ysyQjeyzmBgWyF3JJwi_l1NzI2WF_UcumjjFwIM01KmKc1IMc40NAjKyYiQTGHFOEH1RE3YBQi7qFzuHhpAzwm9WYyMPV3B0Y87lEqKfA3d6uOzuEF5WqW3zVZ8AwY6dVg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=THIADIAZOLINE+DERIVATIVE&rft.inventor=KATO%2C+KAZUHIKO&rft.inventor=MURAKATA%2C+CHIKARA&rft.inventor=YAMASHITA%2C+YOSHINORI&rft.inventor=INO%2C+YOJI&rft.inventor=NAKAI%2C+RYUICHIRO&rft.inventor=TAKAHASHI%2C+TAKESHI&rft.inventor=NAKANO%2C+TOMOHISA&rft.inventor=OHTA%2C+YOSHIHISA&rft.date=2011-06-21&rft.externalDBID=C&rft.externalDocID=CA2469801C